Biotricity, Inc.
BTCY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,931 | $9,733 | $7,779 | $7,024 |
| - Cash | $308 | $391 | $365 | $510 |
| + Debt | $13,469 | $26,584 | $26,090 | $25,456 |
| Enterprise Value | $27,091 | $35,926 | $33,504 | $31,970 |
| Revenue | $3,886 | $3,874 | $3,703 | $3,619 |
| % Growth | 0.3% | 4.6% | 2.3% | – |
| Gross Profit | $3,181 | $3,117 | $2,978 | $2,764 |
| % Margin | 81.9% | 80.5% | 80.4% | 76.4% |
| EBITDA | $372 | $333 | -$878 | -$87 |
| % Margin | 9.6% | 8.6% | -23.7% | -2.4% |
| Net Income | -$691 | -$672 | -$1,936 | -$1,229 |
| % Margin | -17.8% | -17.3% | -52.3% | -34% |
| EPS Diluted | -0.026 | -0.029 | -0.088 | -0.054 |
| % Growth | 8.4% | 67.5% | -62.5% | – |
| Operating Cash Flow | $416 | -$373 | -$401 | -$88 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $416 | -$373 | -$401 | -$88 |